Prothena Corporation plc
PRTA
$9.60
$0.171.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 57.94M | 9.68M | 11.79M | 10.34M | 137.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.94M | 9.68M | 11.79M | 10.34M | 137.94M |
| Cost of Revenue | 96.67M | 134.85M | 170.44M | 192.22M | 209.22M |
| Gross Profit | -38.73M | -125.17M | -158.65M | -181.88M | -71.28M |
| SG&A Expenses | 54.46M | 59.39M | 63.59M | 67.12M | 67.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 151.13M | 194.24M | 234.03M | 259.34M | 276.55M |
| Operating Income | -93.19M | -184.56M | -222.25M | -249.00M | -138.61M |
| Income Before Tax | -106.73M | -200.83M | -238.75M | -261.68M | -115.86M |
| Income Tax Expenses | 44.44M | 43.26M | 41.71M | 41.24M | -5.60M |
| Earnings from Continuing Operations | -151.18 | -244.09 | -280.46 | -302.92 | -110.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -151.18M | -244.09M | -280.46M | -302.92M | -110.27M |
| EBIT | -93.19M | -184.56M | -222.25M | -249.00M | -138.61M |
| EBITDA | -92.33M | -183.67M | -221.35M | -248.10M | -137.71M |
| EPS Basic | -2.81 | -4.53 | -5.21 | -5.63 | -2.05 |
| Normalized Basic EPS | -0.94 | -1.98 | -2.39 | -2.66 | -1.35 |
| EPS Diluted | -2.82 | -4.54 | -5.22 | -5.63 | -2.07 |
| Normalized Diluted EPS | -0.94 | -1.98 | -2.39 | -2.66 | -1.36 |
| Average Basic Shares Outstanding | 215.20M | 215.32M | 215.30M | 215.26M | 215.20M |
| Average Diluted Shares Outstanding | 215.60M | 215.32M | 215.30M | 215.26M | 216.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |